CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
68 hedge funds and large institutions have $159M invested in Concert Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
+14
Holders Change %
+25.93%
% of All Funds
1.81%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
20
Increased
24
Reduced
14
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$10M |
2 |
Jennison Associates
New York
|
+$7.27M |
3 |
SAM
Senzar Asset Management
New York
|
+$3.78M |
4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.41M |
5 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
+$2.24M |